Tech Company M&A Transactions
Cavion Acquisition
Cavion, operating out of Charlottesville, was acquired by Jazz Pharmaceuticals. Jazz Pharmaceuticals said the transaction price was $312.5 million.
Transaction Overview
Company Name
Acquired By
Announced On
8/13/2019
Transaction Type
M&A
Amount
$312,500,000
M&A Terms
Under the terms of the deal, which was made possible through a merger with a Jazz subsidiary, the former Cavion shareholders receive an upfront payment of $52.5m and have the potential to receive additional payments of up to $260.0m upon the achievement of certain clinical, regulatory and commercial milestones, for a total potential consideration of $312.5m.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
600 East Water St. E
Charlottesville, VA 22902
USA
Charlottesville, VA 22902
USA
Phone
Website
Email Address
Overview
Cavion is a clinical stage pharmaceutical company committed to providing patients with therapies for neurologic diseases and cancer through the development of drugs that selectively inhibit the T-type calcium channel (Cav3).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andrew Krouse
Chief Financial Officer
Kurt Woerpel
Chief Medical Officer
Spyros Papapetropoulos
VP - Bus. Development
Anne Heldreth
VP - Operations
Paul Sartori
Browse more venture capital transactions:
Prev: 8/13/2019: Nutriati venture capital transaction
Next: 8/13/2019: Attentive venture capital transaction
Share this article
News on VC Transactions
We do our best to record every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs